Hepatitis: all 3,372 studies
Page 31 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C VirusCompletedNCT00529321Phase 1
- Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis PatientsCompletedNCT00527774
- Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis CCompletedNCT00527540Phase 3
- A Study of the PK, Safety and Antiviral Activity of A-831 in HCV CarriersTerminatedNCT00522808Phase 1/2
- Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior TreatmentCompletedNCT00519792Phase 1
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.CompletedNCT00517439Phase 2
- A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarriersCompletedNCT00516945Not applicable
- Factors Associated to Success of Hepatitis C TherapyCompletedNCT00514111
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedNCT00513968Phase 1
- Laboratory Profile of Hepatitis B and C in Users of a Reference ServiceCompletedNCT00512941
- Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusCompletedNCT00503347Phase 1
- Short Course of Interferon Treatment in Patients With HCV InfectionCompletedNCT00502970Phase 4
- Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)CompletedNCT00502788Phase 2
- Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4CompletedNCT00502099Phase 4
- Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.CompletedNCT00502086Phase 3
- Chiron Corp HCV E1/E2 VaccineCompletedNCT00500747Phase 1
- Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C VirusStatus unknownNCT00499434
- A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal DiseaseTerminatedNCT00498212Phase 2
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
- Reducing Depressive Symptoms During HCV Therapy: A Randomized StudyStatus unknownNCT00495768Not applicable
- Effects of HIV and Hepatitis C Virus on the BrainCompletedNCT00494936
- Mucomyst for Hepatitis CSuspendedNCT00493610Not applicable
- A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)CompletedNCT00489099Phase 3
- Fluvastatin, Rosuvastatin Added to Pegylated Interferon and RibavirinCompletedNCT00487318Phase 2
- RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of RibavirinStatus unknownNCT00485342Phase 3
- Ribavirin, Its Dosing RegimeCompletedNCT00484328Phase 4
- Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster DoseCompletedNCT00483470Phase 3
- Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month ScheduleCompletedNCT00480116Phase 3
- HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infectionCompletedNCT00476723
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.CompletedNCT00475072Phase 4
- Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, SwitzerlandCompletedNCT00473993
- An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00467545Phase 4
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver TransplantCompletedNCT00466219Phase 3
- Protein Biomarker in Hepatocellular CarcinomaTerminatedNCT00465842
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.TerminatedNCT00460850Phase 4
- Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and RibavirinTerminatedNCT00456248Phase 4
- Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2Status unknownNCT00451984Phase 3
- TG4040 in Patients With Chronic HCVWithdrawnNCT00449124Phase 1
- Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis CCompletedNCT00446940Phase 2
- Phase I Hepatitis C Vaccine Trial of Virosome-formulated PeptidesCompletedNCT00445419Phase 1
- Oxidative Stress and Fatty Acids in Hepatitis CCompletedNCT00444002
- Fluvastatin Versus Hepatitis C VirusCompletedNCT00441493Not applicable
- Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected AdultsTerminatedNCT00439959Phase 1
- Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) TherapyStatus unknownNCT00437684Phase 3
- Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyStatus unknownNCT00437476Phase 3
- Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis CCompletedNCT00433108Phase 2
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
- Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure PatientsCompletedNCT00426712Phase 1
- Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.CompletedNCT00422838
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CCompletedNCT00421434Phase 2/3
- Study of Nitazoxanide in the Treatment of Chronic Hepatitis CCompletedNCT00418639Phase 2
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
- Efficacy of Silymarin for Acute HepatitisCompletedNCT00412763Phase 4
- SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.CompletedNCT00412334Phase 4
- Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine ChallengeCompletedNCT00411697Phase 4
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3CompletedNCT00411385Phase 3
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
- Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.Status unknownNCT00408304Phase 2
- Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
- Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C VirusCompletedNCT00403533Phase 2
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNCT00402428Phase 3
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C InfectionTerminatedNCT00401947Phase 2
- Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
- Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis CStatus unknownNCT00399815
- Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)CompletedNCT00399672Not applicable
- Study to Evaluate Drug-drug Interaction Between Valopicitabine and RibavirinCompletedNCT00395421Phase 2
- Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected PatientsCompletedNCT00391638Phase 2/3
- Study to Reduce Intravenous Exposures (STRIVE)CompletedNCT00391482Phase 2/3
- Phase I Trial of Silymarin for Chronic Liver DiseasesCompletedNCT00389376Phase 1
- A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.CompletedNCT00389298Phase 1/2
- Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in HumanCompletedNCT00388323Not applicable
- Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.CompletedNCT00383864Phase 4
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383591Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383383Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383227Phase 3
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)WithdrawnNCT00381017Phase 3
- A Randomized Controlled Trial of Lamivudine in Acute Hepatitis BCompletedNCT00380614Phase 4
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.CompletedNCT00377182Phase 2
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard TherapyCompletedNCT00372983Phase 1
- Rosuvastatin for Hepatitis CWithdrawnNCT00371579Not applicable
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceStatus unknownNCT00370617Phase 4
- Transplant-Related Accelerated Progression of Hepatitis CCompletedNCT00368225
- A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder SubjectsCompletedNCT00367887Phase 2
- KRN7000 in Chronic Hepatitis BCompletedNCT00363155Phase 1/2
- Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201TerminatedNCT00362700Phase 2
- Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 TrialCompletedNCT00362674
- Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB InfectionCompletedNCT00362635Phase 3
- Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 TrialsTerminatedNCT00362505Phase 3
- Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®CompletedNCT00362427Phase 2
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibCompletedNCT00356564Phase 4
- A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321CompletedNCT00354861Phase 1
- A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
- Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C InfectionCompletedNCT00352235Phase 1/2
- Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol TherapyCompletedNCT00351871Phase 4